Jeffrey Fineman

Dr. Jeffrey Fineman is a pediatric critical care specialist who serves as chief of the pediatric critical care division. He is an associate investigator in the UCSF Cardiovascular Research Institute. His research has focused on diseases related to pulmonary circulation and has led to new therapies for pulmonary hypertension, including a drug called inhaled nitric oxide that was approved by the Food and Drug Administration. His laboratory, funded by the National Institutes of Health, investigates disease processes in the body involved in pulmonary hypertension.

Fineman earned his medical degree at New York University Grossman School of Medicine and completed a residency in pediatrics at NYU Langone Health's Bellevue Hospital Center, serving as chief resident. He completed a fellowship in pediatric critical care medicine at UCSF before joining the staff.